EP 0958365 A1 19991124 - GRANULOCYTE CHEMOTACTIC PROTEIN 2 VARIANT
Title (en)
GRANULOCYTE CHEMOTACTIC PROTEIN 2 VARIANT
Title (de)
CHEMOTAKTISCHE PROTEIN-2 VARIANTE FÜR GRANULOZYTEN
Title (fr)
VARIANTE DE LA PROTEINE-2 CHIMIOTACTIQUE DE GRANULOCYTES
Publication
Application
Priority
- US 9716034 W 19970910
- US 71328896 A 19960912
Abstract (en)
[origin: WO9811227A1] The present invention provides a polynucleotide which identifies and encodes a novel human granulocyte chemotactic protein 2 variant (NGCP). The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding NGCP. The invention also provides for the production and use of substantially purified NGCP in pharmaceutical compositions to stop cell division in cancerous cells. The invention also describes diagnostic assays which utilize the polynucleotide to hybridize with the transcripts encoding NGCP and anti-NGCP antibodies which specifically bind to NGCP.
IPC 1-7
C12N 15/19; C07K 14/52; A61K 38/19; C12N 15/11; C12Q 1/68; C07K 16/24
IPC 8 full level
C12N 15/09 (2006.01); A61K 38/00 (2006.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); C07K 14/52 (2006.01); C07K 16/18 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/19 (2006.01); C12P 21/02 (2006.01); C12Q 1/68 (2006.01); C12R 1/19 (2006.01)
CPC (source: EP)
A61P 35/00 (2017.12); C07K 14/522 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 9811227A1
Designated contracting state (EPC)
BE DE ES FR GB IT NL
DOCDB simple family (publication)
WO 9811227 A1 19980319; AU 4266197 A 19980402; CA 2265455 A1 19980319; EP 0958365 A1 19991124; JP 2001500019 A 20010109
DOCDB simple family (application)
US 9716034 W 19970910; AU 4266197 A 19970910; CA 2265455 A 19970910; EP 97941010 A 19970910; JP 51382998 A 19970910